[Hypertension and cardiovascular risk: the J-curve concept]

A Yannoutsos1, J-J Mourad, Jacques Blacher

  • 1Unité Hypertension Artérielle, Prévention et Thérapeutique Cardiovasc., Centre de Diagnostic et de Thérapeutique, Hôtel-Dieu, Université Paris.

Praxis
|November 5, 2010
PubMed

Insights

Optimizing pharmacologic treatment for hypertension is crucial due to high prevalence and poor blood pressure control. Lowering blood pressure reduces cardiovascular risk, but overly strict goals may be detrimental.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Hypertension is prevalent, especially in the elderly, with over half of patients lacking adequate blood pressure control.
  • Associated cardiovascular risk factors and residual risk under treatment necessitate optimized pharmacologic strategies.
  • Interventional studies demonstrate a cardiovascular risk reduction proportional to blood pressure lowering.

Purpose of the Study:

  • To evaluate the optimal blood pressure targets in hypertensive patients.
  • To address the controversies surrounding strict blood pressure goals and the J-Curve phenomenon.

Main Methods:

  • Review of interventional studies and clinical trials on hypertension management.
  • Analysis of guidelines for blood pressure targets in different patient populations.
  • Examination of the J-Curve concept regarding cardiovascular morbidity and mortality.

Main Results:

  • Current guidelines suggest targets below 140/90 mmHg for essential hypertension and below 130/80 mmHg for secondary prevention (e.g., diabetes, renal impairment).
  • Clinical trials do not consistently confirm the benefit of strict blood pressure goals in high-risk patients; potentially deleterious effects observed.
  • The "lower the better" concept is being reconsidered due to the J-Curve hypothesis.

Conclusions:

  • The optimal blood pressure target in hypertension requires careful consideration, balancing benefits of reduction against potential risks of overly strict goals.
  • The J-Curve phenomenon, suggesting increased risk with very low blood pressure, remains an area of ongoing research and debate.
  • Individualized treatment strategies are essential for managing hypertension and its associated cardiovascular risks.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.